Skip to main content

Table 3 Stability study of the optimized ALP-loaded NLCs as per the International conference of harmonization (ICH guidelines)

From: RETRACTED ARTICLE: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout

Storage temperature

25 °C ± 2a

40 °C ± 2b

Relative humidity

60% RH ± 5% RH

75% RH ± 5% RH

Time (months)

0

1

3

6

0

1

3

6

Particle size (nm)

238.1 ± 5.3

240.3 ± 5.4

243.9 ± 5.8

247.7 ± 5.8

238.1 ± 5.3

241.5 ± 5.5

245.6 ± 5.2

250.2 ± 5.8

Zeta potential (mV)

-31.5 ± 1.2

-31.0 ± 2.2

-30.8 ± 1.8

-30.2 ± 1.8

-31.5 ± 1.2

-30.6 ± 2.0

-30.1 ± 1.5

-29.3 ± 1.8

PDI

0.115 ± 0.02

0.118 ± 0.02

0.119 ± 0.03

0.121 ± 0.05

0.115 ± 0.02

0.117 ± 0.01

0.124 ± 0.02

0.129 ± 0.04

Entrapment efficiency

(%)

87.3 ± 1.3

85.9 ± 1.4

85.19 ± 1.5

84.11 ± 1.5

87.3 ± 1.3

85.16 ± 1.4

84.54 ± 1.7

83.17 ± 1.5

  1. All the values here represent mean ± standard deviation; n = 3
  2. PDI Polydispersity Index, nm Nanometer, mV Millivolt
  3. aRepresents the accelerated storage condition for the substance to be stored in refrigerator
  4. bRepresents the accelerated storage condition for general class